In order to provide complete functionality, this web site needs your explicit consent to store browser cookies. If you don't allow cookies, you may not be able to use certain features of the web site including but not limited to: log in, buy products, see personalized content, switch between site cultures. It is recommended that you allow all cookies.
Learn more about our policy
EN
FR
Search for:
Navigation
Services
Preclinical
Clinical
Biotesting
Regulatory
Home
About us
The company
The executive team
The facilities
Our partners
Certifications
Jobs
News & Events
News & Publications
Events
Testimonials
FAQ
Contact
News & Events
>
News & Publications
>
Soluble biomarkers development in osteoarthritis
From discovery to personalized medicine
Published on 29/03/2016
Soluble biomarkers development in osteoarthritis
A review that summarizes current guidance on the use of biomarkers in OA in clinical trials and their utility at five stages, including preclinical development and phase 1 to phase 4 trials. It also presents all the available regulatory requirements.
PubMed
Our latest news
19/10/2022
Clinical Trial in Osteoarthitis
01/04/2022
Clinical trial shows major positive effect of food supplement in hospitalised patients with COVID-19
Read more
News & Publications
Events
Testimonials
© Artialis - All rights reserved
Terms & conditions
-
Privacy Policy
Made by